Cholesterol Wire
Comprehensive News Feed for Cholesterol.
Results 1 - 20 of 752 in Cholesterol
-
Prescriptions for cholestrol therapy filled after the release of Arbiter 6-HALTS study results
... the Arbiter 6-HALTS study on Saturday, Nov. 14 a ' patients new to Niaspan filled 13,255 prescriptions for the cholesterol therapy, an increase of 41% from the week ending Nov. 13. This data comes from Vector OneA : National (VONA), SDI's ... Comment?
-
... Story Zero" when it comes to the health benefits of Shakeology . My family has a history of brutally high cholesterol. In June 2006 with a cholesterol reading of 258, far over the acceptable range of 120-200, my doctor put me on the drug Lipitor . ... Comment?
-
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
... modify the lipid profile may include combination therapy to either raise the high-density lipoprotein (HDL) cholesterol level or further lower the low-density lipoprotein (LDL) cholesterol level. Methods We enrolled patients who had coronary heart ... Comment?
-
Taking Niacin to Lower Cholesteral; Can it Cause Hepatitis
... DROPPED SIGNIFICANTLY WHEN TAKING THE NIACIN. Report Abuse Be the first to answer this question What is Cholesterol? This video animation shows how cholesterol behaves in the blood stream. Cholesterol is a soft, fat-like, waxy substance found in the ... Comment?
-
Statin Therapy with Ezetimibe or Niacin in High-Risk Patients
John J.P. Kastelein, M.D., Ph.D., and Michiel L. Bots, M.D., Ph.D. The use of statin therapy to reduce levels of low-density lipoprotein cholesterol in patients who are at high risk for vascular events results in a 30 to 40% reduction in the rate of clinical events.1 However, many patients continue to be at risk. Comment?
-
The HALTS Trial a " Halting Atherosclerosis or Halted Too Early?
The HALTS Trial - Halting Atherosclerosis or Halted Too Early? Roger S. Blumenthal, M.D., and Erin D. Michos, M.D., M.H.S. In patients with elevated cholesterol levels, statin therapy reduces the incidence of cardiovascular events by 25 to 45%. Despite the administration of a statin, many patients require additional lipid-lowering therapy because ... Comment?
-
Niacin or Ezetimibe and Carotid Intimaa "Media Thickness
... modify the lipid profile may include combination therapy to either raise the high-density lipoprotein (HDL) cholesterol level or further lower the low-density lipoprotein (LDL) cholesterol level. Methods We enrolled patients who had coronary heart ... Comment?
-
SDI Reports: Prescriptions for Patients New to Niaspan Rise 41% in...
... of the Arbiter 6-HALTS study on Saturday, Nov. 14 patients new to Niaspan filled 13,255 prescriptions for the cholesterol therapy, an increase of 41% from the week ending Nov. 13. This data comes from Vector One: National (VONA), SDI's ... Comment?
-
... is considering Pfizer's petition to stop UniLab from importing and selling a generic version of Lipitor, the cholesterol-lowering drug that is the US company's best-selling product. Pfizer has alleged that UniLab violated a patent issued in 1995 for ... Comment?
-
Before You Bite: 5 Thanksgiving Health Benefits
... thought to boast gastrointestinal as well as oral health, prevent the formation of kidney stones, lower 'bad cholesterol,' LDLs and raise the 'good cholesterol' HDLs, aid in recovery from stroke and even help prevent cancer. Certain compounds in ... Comment?
-
Difficult mix of business, science
... Pfizer for the blow it will receive when it loses patent protection in 2011 for its blockbuster drug Lipitor, a cholesterol-fighting medicine that will produce about $11.2 billion in sales this year. Come 2011, the sale of generic alternatives to ... Comment?
-
Wet pj's eased son's eczema November 24, 2009
... how well this approach works for others. Q. I am one of those people who cannot tolerate statin drugs to lower cholesterol. I have taken lovastatin, pravastatin, simvastatin and Lipitor. They make my muscles ache so I cannot exercise. I am concerned ... Comment?
-
Children's Lipitor may be coming to Europe
Pfizer Inc. is trying to market its top-selling cholesterol drug, Lipitor, for children in Europe.Results of new data for Lipitor were submitted to the European Medicines Agency, Pfizer... Comment?
-
Genfit: Extremely Promising Gft505 Results In Phase Ii
... a statistically significant 21% (p=0.0027) reduction of plasma triglycerides and a 9% (p=0.003) increase in good cholesterol (HDL-C) level. These metabolic effects were comparable to those published with the best competitors (fibrates) in the same ... Comment?
-
6th Annual LES Pig Roast | Mason Dixon
Following the debut of Manhattan's first mechanical bull at Johnny Utah's in Midtown, urban rodeo junkies got a sequel of sorts on the Lower East Side with Mason Dixon - a swank saloon from the folks behind Spitzer's Corner . Comment?
-
Questions about questioning Zetia's effectiveness
w/Photo
Merck-Schering-Plough is the manufacturer of Zetia and Vytorin. Associated Press photo. A recent story about the cholesterol-lowering drug, Zetia ("New study raises questions about Merck pill," by Marilynn Marchione, AP Medical Writer, link to Kansas ... Comment?
-
The NMR LipoProfile cholesterol particle size test more accurate measure of heart health risk
It seems just about everyone these days is aware of cholesterol because of the relentless daily barrage of advertisements from the pharmaceutical companies pushing these cholesterol-lowering statin drugs like Lipitor, Crestor, and the like. Comment?
-
How does Zetia and niacin affect the carotid intima-media thickness (CIMT)?
w/Photo
... patients showed no evidence of regression, and in those who achieved the greatest reduction in LDL cholesterol, CIMT paradoxically increased. Niacin led to a significant increase in HDL compared to ezetimibe, while ezetimibe decreased LDL ... Comment?
-
Pfizer's prospects open to debate
... ahead for Pfizer, not the least of which is the 2011 loss of patent protection for its leading medicine, the cholesterol fighter Lipitor. Lipitor is expected to contribute $11.2 billion to Pfizer's drug sales this year. While some have seen Pfizer's ... Comment?
-
Another Vytorin Mess For Merck
The results of a much-awaited study could hardly be worse for Merck 's big-selling cholesterol drugs Zetia and Vytorin. Comment?
Cholesterol Forum
Most Popular
- Hiding evidence of global cooling - Junk science exposed among climate-chang... - 108 comments
- Google won't exclude distorted Michelle Obama image from its site - 118 comments
- Dana Perino Forgets 9/11 Occurred Under Bush - 100 comments
- Palin heads to Fla. town that feted her in 2008 - 95 comments
- 5 Things The U.S. Can LEARN From CHINA - 87 comments
- SEALs accused of hitting alleged Iraq plotter - 42 comments
- Census worker hanging a suicide - 32 comments
- Wild camels terrorize Australian community - 33 comments
- The War on Christmas vs. the War on Thanksgiving - 44 comments
- FYROM emetic propaganda - 53 comments
|
Reach local customers. Engage a specific demographic. Maximize business-to-business opportunities. Topix can deliver your message.
|
Copyright ©2009 Topix LLC
